Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kyle Gano currently holds 141,754 shares of NEUROCRINE BIOSCIENCES INC (NBIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kyle Gano has been a net seller of NBIX stock. They have purchased $0 and sold $34.7M worth of shares.
Kyle Gano's most recent insider trade was on Jan 31, 2026, when they sold 2,927 shares at $0.00 per share.
Kyle Gano serves as Executive at NEUROCRINE BIOSCIENCES INC (NBIX). They have executed 94 insider transactions totaling $34.7M over their tenure at the company.
Kyle Gano holds the position of Executive at NEUROCRINE BIOSCIENCES INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Kyle Gano has shown a selling trading pattern, with $0 in total purchases and $34.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kyle Gano was on Jan 2, 2024, when they sold $9.1M worth of NBIX shares. This transaction involved 68,884 shares at $131.47 per share.
Kyle Gano currently owns 141,754 shares of NEUROCRINE BIOSCIENCES INC (NBIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kyle Gano's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kyle Gano has 94 Form 4 filings on record as an insider at NEUROCRINE BIOSCIENCES INC.
Set alerts for Kyle Gano and 40,000+ other insiders.